ReviewFrontiers in oncology2022

Cellular Therapy in High-Risk Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter Syndrome.

Maria Chiara Barbanti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.